GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by Sequoia Financial Advisors LLC

Sequoia Financial Advisors LLC increased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,340 shares of the company’s stock after buying an additional 1,123 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in GE HealthCare Technologies were worth $1,121,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Darwin Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies in the third quarter valued at about $31,000. Continuum Advisory LLC increased its holdings in GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after buying an additional 168 shares during the period. Bank of Jackson Hole Trust purchased a new position in GE HealthCare Technologies during the 4th quarter worth approximately $32,000. OFI Invest Asset Management acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter worth $34,000. Finally, Avion Wealth lifted its position in GE HealthCare Technologies by 497.4% during the fourth quarter. Avion Wealth now owns 460 shares of the company’s stock valued at $35,000 after purchasing an additional 383 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Up 0.6 %

GEHC opened at $81.97 on Friday. The firm has a market capitalization of $37.48 billion, a price-to-earnings ratio of 18.93, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. The company’s 50 day simple moving average is $87.26 and its two-hundred day simple moving average is $86.12. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently commented on GEHC shares. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and raised their target price for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Wells Fargo & Company increased their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, February 14th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price target for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Citigroup increased their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. One analyst has rated the stock with a sell rating, two have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $98.75.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.